Skip to Main Content
Welcome to theĀ Scientist.comĀ Marketplace

Go to Main Navigation

TL307274V

SRD5A3 Human shRNA Lentiviral Particle (Locus ID 79644)

Origene Technologies, Inc.

DESCRIPTION

SRD5A3 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

DETAILS

  • Format: Lentiviral particles
  • Refseq: NM_024592, NM_024592.1, NM_024592.2, NM_024592.3, NM_024592.4, BC002480, BC002480.2, NM_024592.5
  • Status: 5 Weeks*
  • Vector: pGFP-C-shLenti
  • Summary: The protein encoded by this gene belongs to the steroid 5-alpha reductase family, and polyprenol reductase subfamily. It is involved in the production of androgen 5-alpha-dihydrotestosterone (DHT) from testosterone, and maintenance of the androgen-androgen receptor activation pathway. This protein is also necessary for the conversion of polyprenol into dolichol, which is required for the synthesis of dolichol-linked monosaccharides and the oligosaccharide precursor used for N-linked glycosylation of proteins. Mutations in this gene are associated with congenital disorder of glycosylation type Iq. [provided by RefSeq, Mar 2011]
  • Category: RNAi
  • Locus Id: 79644
  • Synonyms: CDG1P; CDG1Q; KRIZI; SRD5A2L; SRD5A2L1
  • Uniprot Id: Q9H8P0
  • Availability: 5 Weeks
  • Shrna Design: These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
  • Performance Guaranteed: OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).